Inactive Instrument

Calendar Antisense Therapeutics Limited Other OTC

Equities

ATHJF

AU000000ANP4

Chart calendar Antisense Therapeutics Limited

b6e3bdd223f5e8a6b.cKDpTjJDKjeVzYbRU3k1e03kAZt8URhOfJeHqOTc-xI.JcjfDH07XALDgPyfNlR7NifUY-IbYC4vOdTV0oe3iSsi2dwbXy9rfvf_tg~05e6e53c9e8e3aaf179fb7837d649ca9

Upcoming events on Antisense Therapeutics Limited

28/08/2024 Q4 2024 Earnings Release (Projected)
26/02/2025 Q2 2025 Earnings Release (Projected)
27/08/2025 Q4 2025 Earnings Release (Projected)
04/03/2026 Q2 2026 Earnings Release (Projected)

Past events on Antisense Therapeutics Limited

Today Bio International Convention
30/04/2024 04:23 am March 2024 Sales and Revenue Release - Activities Report
03/03/2024 Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V410
03/03/2024 Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V409
03/03/2024 Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - M149
28/02/2024 11:50 am Q2 2024 Earnings Release
31/01/2024 03:42 am December 2023 Sales and Revenue Release - Activities Report
08/01/2024 JPMorgan Healthcare Conference
08/01/2024 Biotech Showcase
15/11/2023 08:30 am Annual General Meeting
01/11/2023 AusBiotech Conference
31/10/2023 04:08 am September 2023 Sales and Revenue Release - Activities Report
18/10/2023 02:15 am BIO Investor Forum
08/09/2023 09:30 am ShareCafe Small Cap Hidden Gems Conference
25/08/2023 01:38 pm Q4 2023 Earnings Release
28/07/2023 05:07 am June 2023 Sales and Revenue Release - Activities Report
17/04/2023 05:08 am March 2023 Sales and Revenue Release - Activities Report
22/02/2023 10:54 am Interim 2023 Earnings Release
25/01/2023 December 2022 Sales and Revenue Release - Activities Report
17/11/2022 08:30 am Annual General Meeting

Annual results

Fiscal PeriodJuni 2020 2021 2022 2023 2024
Net sales
Million AUD
Released
Forecast
Spread
0,77


0,64
6,30
-89.89%
1,81
1,40
29.41%
1,96
1,80
9.15%

3,60

EBITDA
Million AUD
Released
Forecast
Spread
0,00


-7,95
-8,88
10.49%
-5,71
-11,3
49.31%
-11,3
-12,1
7.07%

-13,2

EBIT
Million AUD
Released
Forecast
Spread
0,00


-8,05
-8,87
9.28%
-5,80
-11,3
48.6%
-11,4
-12,2
6.66%

-13,3

Earnings before Tax (EBT)
Million AUD
Released
Forecast
Spread
0,00


-8,06
-8,20
1.7%
0,00
0,00
-
-11,4
-8,80
-29.32%

-17,2

Net income
Million AUD
Released
Forecast
Spread
0,00


-8,06
-8,96
10.02%
0,00
0,00
-
-11,4
-11,9
4.72%

-17,2

EPS
AUD
Released
Forecast
Spread
0,00


-0,01
-0,02
6.88%
0,00
0,00
-
-0,02
-0,02
4.39%

-0,02

Announcement Date26/08/2025/08/2131/08/2225/08/23-

Quarterly results

Fiscal PeriodJuni 2021 S2 2024 S1
Net sales
Million AUD
Released
Forecast
Spread



1,20
0,00
-
EBITDA
Million AUD
Released
Forecast
Spread
-6,01
-6,00
-0.17%
-4,69
-8,50
44.78%
EBIT
Million AUD
Released
Forecast
Spread
-6,01
-6,00
-0.17%
-4,74
-8,50
44.23%
Net income
Million AUD
Released
Forecast
Spread



-4,74
-8,60
44.85%
EPS
AUD
Released
Forecast
Spread



-0,01
-0,01
40%
Announcement Date25/08/2128/02/24
  1. Stock Market
  2. Equities
  3. PER Stock
  4. ATHJF Stock
  5. Calendar Antisense Therapeutics Limited